1887

Chapter 21 : : a Sugar-Coated Killer

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

: a Sugar-Coated Killer, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap21-1.gif /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap21-2.gif

Abstract:

The main principles for the genetic pathophysiology of cryptococcosis will probably be consistent among all three varieties. In this chapter the author considers the yeasts to be different varieties or serotypes. Seven major areas are examined to support the potential molecular insights into this pathogenic yeast which will allow one to identify drug targets, define drug resistance mechanisms, and/or prepare mutants or fungal products for protective fungal vaccines. Initial molecular biology studies focused on distinguishing molecular strain differences with the use of karyotypes, repetitive elements, and eventually randomly amplified polymorphic DNAs, amplification fragment length polymorphisms, and PCR fingerprinting for strain genotyping. has several well-characterized virulence phenotypes which have been approached in their understanding by both genetic and molecular tools. Experimental cryptococcosis in animal models has tended to be associated with large inocula or some type of induced immunosuppression. In summary, the encapsulated yeast has developed into a major human pathogen over the last two decades. It causes a serious infection which we can treat, but it is still associated with substantial morbidity and mortality and is correctly called the sugar-coated killer In , all the keys are in place to unlock the mysteries of what it means to be a fungal pathogen. This basidiomycete has become a model pathogen for the study of molecular fungal pathogenesis, and although it has unique features, many of the paradigms discovered by its study will be used to understand other invasive mycoses.

Citation: Perfect J. 2006. : a Sugar-Coated Killer, p 281-303. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch21

Key Concept Ranking

Acute Respiratory Distress Syndrome
0.43163761
Nuclear Magnetic Resonance Spectroscopy
0.40849954
0.43163761
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

India ink preparation from cerebrospinal fluid, showing encapsulated yeasts ().

Citation: Perfect J. 2006. : a Sugar-Coated Killer, p 281-303. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815776.ch21
1. Aguirre, K.,, E. A. Havell,, G. W. Gibson, and, L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:17251731.
2. Akhter, S.,, H. C. McDade,, J. M. Gorlach,, G. Heinrich,, G. M. Cox, and, J. R. Perfect. 2003. Role of alternative oxidase gene in pathogenesis of Cryptococcus neofor-mans variety grubii. Infect. Immun. 71:48314841.
3. Alspaugh, J. A.,, L. M. Cavallo,, J. R. Perfect, and, J. Heitman. 2000. RAS1 regulates filamentation, mating, and growth at high temperature of Cryptococcus neofor-mans. Mol. Microbiol. 36:352365.
4. Alspaugh, J. A.,, J. R. Perfect, and, J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11:32063217.
5. Alspaugh, J. A.,, R. Pukkila-Worley,, T. Harashima,, L. M. Cavallo,, D. Funnell,, G. M. Cox,, J. R. Perfect,, J. W. Kronstad, and, J. Heitman. 2002. Adenylyl cyclase functions downstream of the G-alpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot. Cell 1:7584.
6. Apidianakis, Y.,, L. G. Rhame,, J. Heitman,, F. M. Ausubel,, S. B. Calderwood, and, E. Mylonakis. 2004. Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot. Cell 3:413419.
7. Arend, S. M.,, E. J. Kuijper,, C. F. Allaart,, W. H. Muller, and, J. T. Van Dissel. 2004. Cavitating pneumonia after treatment with infliximab and prednisone. Eur. J. Clin. Microbiol. Infect. Dis. 23:638641.
8. Bahn, Y. S.,, J. K. Hicks,, S. S. Giles,, G. M. Cox, and, J. Heitman. 2004. Adenylyl cyclase-associated protein Aca1 regulates virulence and differentiation of Cryptococcus neoformans via the cyclic AMP-protein kinase A cascade. Eukaryot. Cell 3:14761491.
9. Baker, R. D., and, R. K. Haugen. 1955. Tissue changes and tissue diagnosis of cryptococcosis: a study of 26 cases. Am. J. Pathol. 25:14.
10. Biondo, C.,, C. Beninati,, D. Delfino,, M. Oggioni,, G. Mancuso,, A. Midiri,, M. Bombaci,, G. Tomaselli, and, G. Teti. 2002. Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infect. Immun. 70:23832391.
11. Blasi, E.,, A. Brozzetti,, D. Francisci,, R. Neglia,, G. Cardinal,, F. Ristoni,, V. Vidotto, and, F. Baldelli. 2001. Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur. J. Clin. Microbiol. 20:535543.
12. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:42114218.
13. Casadevall, A., and, J. Perfect. (ed.). 1998. Cryptococcus neoformans. ASM Press, Washington, D.C.
14. Casadevall, A., and, J. R. Perfect. 1998. Virulence factors, p. 145176. In A. J. Casadevall and, J. R. Perfect (ed.), Cryptococcus neoformans. ASM Press, Washington, D.C.
15. Casadevall, A.,, J. N. Steenbergen, and, J. D. Nosanchuk. 2003. “Ready made” virulence and “dual use” virulence factors in pathogenic environmental fungi—the Cryptococcus neoformans paradigm. Curr. Opin. Microbiol. 6:332337.
16. Chang, Y.,, L. Penoyer, and, K. J. Kwon-Chung. 1996. The second capsule gene of Cryptococcus neoformans CAP64 is essential for virulence. Infect. Immun. 64:19771983.
17. Chang, Y. C.,, R. Cherniak,, T. R. Kozel,, D. L. Granger,, L. C. Morris,, L. C. Weinhold, and, K. J. Kwon-Chung. 1997. Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with CAP64 gene. Infect. Immun. 65:15841592.
18. Chang, Y. C., and, K. J. Kwon-Chung. 1994. Complementation of a capsule-deficiency mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:49124919.
19. Chang, Y. C., and, K. J. Kwon-Chung. 1998. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:22302236.
20. Chang, Y. C., and, K. J. Kwon-Chung. 1999. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J. Bacteriol. 181:56365643.
21. Chang, Y. C.,, G. F. Miller, and, K. J. Kwon-Chung. 2003. Importance of a developmentally regulated pheromone receptor of Cryptococcus neoformans for virulence. Infect. Immun. 71:49534960.
22. Chang, Y. C.,, L. A. Penoyer, and, K. J. Kwon-Chung. 1996. The second capsule gene of Cryptococcus neofor-mans, CAP 64, is essential for virulence. Infect. Immun. 64:19771983.
23. Chang, Y. C.,, L. A. Penoyer, and, K. J. Kwon-Chung. 2001. The second STE12 homologue of Cryptococcus neoformans is MAT a-specific and plays an important role in virulence. Proc. Natl. Acad. Sci. USA 98:32583263.
24. Chang, Y. C.,, M. F. Stins,, M. J. McCaffery,, G. F. Miller,, D. R. Pare,, T. Dam,, M. Paul-Satyaseela,, K. S. Kim,, K. J. Kwon-Chung, and, M. Paul-Satyasee. 2004. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect. Immun. 72:49854995.
25. Chaturvedi, V. P.,, T. Flynn,, W. G. Niehaus, and, B. Wong. 1996. Stress tolerance and pathogenic potential of a mannitol-mutant of Cryptococcus neoformans. Microbiology 142:937943.
26. (Reference deleted.)
27. Cherniak, R. L.,, L. C. Morris,, T. Belay,, E. D. Spitzer, and, A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:18991905.
28. Chretien, F.,, O. Lortholary,, I. Kansau,, S. Neuville,, F. Gray, and, F. Dromer. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186:522530.
29. Chung, S.,, P. Mondon,, Y. C. Chang, and, K. J. Kwon-Chung. 2003. Cryptococcus neoformans with a mutation in the tetra tricopeptide repeat-containing gene, CCN1, causes subcutaneous lesions but fails to cause systemic infection. Infect. Immun. 71:19881994.
30. Clumeck, N.,, J. Sonnet,, H. Taelman,, F. Mascart-Lemone,, M. De Bruyere,, P. Vandeperre,, J. Dasnoy,, L. Marcelis,, M. Lamy,, C. Jonas,, L. Eyckmans,, H. Noel,, M. Vanhaeverbeek, and, J.-P. Butzler. 1984. Acquired immunodeficiency syndrome in African patients. N. Engl. J. Med. 310:492497.
31. Cox, G. M.,, T. S. Harrison,, C. P. Taborda,, H. C. McDade,, G. Heinrich,, A. Casadevall, and, J. R. Perfect. 2003. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 71:173180.
32. Cox, G. M.,, H. C. McDade,, S. C. Chen,, S. C. Tucker,, M. Gottfredsson,, L. C. Wright,, T. C. Sorrell,, S. D. Leidich,, A. Casadevall,, M. A. Ghannoum, and, J. R. Perfect. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:166175.
33. Cox, G. M.,, J. Mukherjee,, G. T. Cole,, A. Casadevall, and, J. R. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443448.
34. Cox, G. M.,, D. L. Toffaletti, and, J. R. Perfect. 1996. Dominant selection system for use in Cryptococcus neoformans. J. Med. Vet. Mycol. 34:385391.
35. Crowe, S. M.,, J. B. Carlin,, K. I. Stewart,, C. R. Lucas, and, J. F. Hoy. 1991. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J. Acquir. Immune Defic. Syndr. 4:770776.
36. Cruz, M. C.,, L. Cavallo,, J. Gorlach,, J. R. Perfect,, M. E. Cardenas, and, J. Heitman. 1999. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and Tor kinase homologs in C. neoformans. Mol. Cell. Biol. 19:41014112.
37. Currie, B. P.,, L. F. Freundlich, and, A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:11881192.
38. Davidson, R. C.,, M. C. Cruz,, R. A. Sia,, B. Allen,, J. A. Alspaugh, and, J. Heitman. 2000. Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans. Fungal Genet. Biol. 29:3848.
39. Davidson, R. C.,, C. B. Nichols,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2003. A MAP kinase cascade composed of cell type specific and non-specific elements controls mating and differentiation of the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 49:469485.
40. de Jesus-Berrios, M.,, L. Liv,, J. C. Nussbaum,, G. M. Cox,, J. S. Stamler, and, J. Heitman. 2003. Enzymes that counteract nitrosative stress promote fungal virulence. Curr. Biol. 13:19631968.
41. Del Poeta, M.,, D. L. Toffaletti,, T. H. Rude,, C. C. Dykstra,, J. Heitman, and, J. R. Perfect. 1999. Topoisomerase 1 is essential in Cryptococcus neofor-mans: role in pathobiology and as an antifungal target. Genetics 152:167178.
42. Del Poeta, M.,, D. L. Toffaletti,, T. H. Rude,, S. D. Sparks,, J. Heitman, and, J. R. Perfect. 1999. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein. Infect. Immun. 67:18121820.
43. Devi, S. J. N. 1996. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine 14:841842.
44. (Reference deleted.)
45. D’Souza, C. A.,, J. A. Alspaugh,, C. Yue,, T. Harashima,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2001. Cyclic-AMP-dependent protein kinase controls virulence of the fungal pathogen, Cryptococcus neoformans. Mol. Cell. Biol. 21:31793191.
46. D’Souza, C. A.,, F. Hagen,, T. Boekhout,, G. M. Cox, and, J. Heitman. 2004. Investigation of the basis of virulence in serotype A strains of Cryptococcus neoformans from apparently immunocompetent individuals. Curr. Genet. 46:92102.
47. Dykstra, M. A.,, L. Friedman, and, J. W. Murphy. 1977. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect. Immun. 16:129.
48. Edman, J. C., and, K. J. Kwon-Chung. 1990. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10:45384544.
49. Erickson, T.,, L. Liu,, A. Gueylkian,, X. Zhu,, J. Gibbons, and, P. R. Williamson. 2001. Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol. Microbiol. 42:11211131.
50. Falkow, S. 1988. Molecular Koch’s postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10:52745276.
51. Feldmesser, M.,, Y. Kress,, P. Novikoff, and, A. Casadevall. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:42254237.
52. Fox D. S.,, G. M. Cox, and, J. Heitman. 2003. Phospholipid-binding protein Cts1 controls septation and functions coordinately with calcineurin in Cryptococcus neoformans. Eukaryot. Cell 2:10251035.
53. Fox, D. S.,, M. C. Cruz,, R. A. Sia,, H. Ke,, G. M. Cox,, M. E. Cardenas, and, J. Heitman. 2001. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol. Microbiol. 39:835849.
54. Franzot, S. P.,, J. Mukherjee,, R. Cherniak,, L. Chen,, J. S. Hamdan, and, A. Casadevall. 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect. Immun. 66:8997.
55. Franzot, S. P.,, I. F. Salkin, and, A. Casadevall. 1999. Cryptococcus neoformans var. grubii: separate variety status for Cryptococcus neoformans serotype A isolates. J. Clin. Microbiol. 37:838840.
56. Fraser, J. A., and, J. Heitman. 2003. Fungal mating-type loci. Curr. Biol. 13:R792R795.
57. Fries, B. C.,, E. Cook,, X. Wang, and, A. Casadevall. 2005. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans. Antimicrob. Agents Chemother. 49:350357.
58. Fries, B. C.,, D. L. Goldman, and, A. Casadevall. 2002. Phenotypic switching in Cryptococcus neoformans. Microbiol. Infect. Dis. 4:13451352.
59. Garcia-Hermoso, D.,, F. Dromer, and, G. Janbon. 2004. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72:33593365.
60. Garcia-Hermoso, D.,, G. Janbon, and, F. Dromer. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J. Clin. Microbiol. 37:32043209.
61. Garcia-Rivera, J.,, Y. C. Chang,, C. J. Kwon-Chung, and, A. Casadevall. 2004. CAP59 is involved in the extra cellular trafficking of capsular glucoronoxylomannan. Eukaryot. Cell 3:385392.
62. Giles, S. S.,, I. Batinic-Haberle,, J. Perfect, and, G. M. Cox. 2005. Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth. Eukaryot. Cell 4:4654.
63. Giles, S. S.,, J. R. Perfect, and, G. M. Cox. 2005. Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformans. Fungal Genet. Biol. 42:2029.
64. Goldman, D. L.,, B. C. Fries,, S. P. Franzot,, L. Montella, and, A. Casadevall. 1998. Phenotypic switching in the human pathogenic fungus, Cryptococcus neoformans, is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl. Acad. Sci. USA 95:1496714972.
65. Goldman, D. L.,, H. Khine, and, J. Abadi. 2001. Serologic evidence for cryptococcus infection in early childhood. Pediatrics 107:66.
66. Gorlach, J.,, D. S. Fox,, N. S. Cutler,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2000. Identification and characterization of a highly conserved calcineurin binding protein CBP1/calcipressin in Cryptococcus neoformans. EMBO J. 19:36183629.
67. Gorlach, J. M.,, H. C. McDade,, J. R. Perfect, and, G. M. Cox. 2002. Antisense repression in Cryptococcus neoformans as a laboratory tool and potential antifungal strategy. Microbiology 148:213219.
68. Granger, D. L.,, J. R. Perfect, and, D. T. Durack. 1985. Virulence of Cryptococcus neoformans: regulation of capsule synthesis by carbon dioxide. J. Clin. Investig. 76:508516.
69. Graybill, J. R.,, J. Sobel,, M. Saag,, C. van der Horst,, W. Powderly,, G. Cloud,, L. Riser,, R. J. Hamil, and, W. Dismukes. 2000. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin. Infect. Dis. 30:4754.
70. Griffith, C. L.,, J. S. Klutts,, L. Zhang,, S. B. Levery, and, T. L. Doering. 2004. UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J. Biol. Chem. 279:5166951676.
71. Hajjman, A.,, L. A. Conn,, D. S. Stephens, and the Cryptococcal Active Surveillance Group. 1999. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J. Infect. Dis. 179:449454.
72. Hakim, J. G.,, I. T. Gangaidzo, and, R. S. Heyderman. 2000. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 14:14011407.
73. Haynes, K. A.,, D. J. Sullivan,, D. C. Coleman,, J. C. K. Clarke,, R. Emilianus,, J. Atkinson, and, K. J. Cann. 1995. Involvement of multiple Cryptococcus neofor-mans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J. Clin. Microbiol. 33:99102.
74. Heung, L. J.,, C. Luberto,, A. Plowden,, Y. A. Hannun, and, M. Del Poeta. 2004. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J. Biol Chem. 279:2114421153.
75. Hicks, J. K.,, C. D’Souza,, G. M. Cox, and, J. Heitman. 2004. Cyclic AMP-dependent protein kinase catalytic subunits have divergent roles in virulence factor production in two varieties of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 3:1428.
76. Hill, J. O. 1992. CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:16851695.
77. Hua, J.,, J. D. Meyer, and, J. K. Lodge. 2000. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 7:125128.
78. Huffnagle, G. B.,, R. M. Strieter, and, L. K. McNeil. 1997. Macrophage inflammatory protein-1 alpha (MIP-alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318327.
79. Huffnagle, G. B.,, T. R. Traynor, and, R. A. McDonald. 2000. Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. Immunopharmacology 48:231236.
80. Huffnagle, G. B.,, J. L. Yates, and, M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:14231433.
81. Hull, C. M.,, G. M. Cox, and, J. Heitman. 2004. The alpha-specific cell identity factor Sxi1α is not required for virulence of Cryptococcus neoformans. Infect. Immun. 72:36433645.
82. Hull, C. M., and, J. Heitman. 2002. Genetics of Cryptococcus neoformans. Annu. Rev. Genet. 36:557615.
83. Husain, S.,, M. M. Wagner, and, N. Singh. 2001. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg. Infect. Dis. 7:375381.
84. Idnurm, A.,, J. L. Reedy,, J. C. Nussbaum, and, J. Heitman. 2004. Cryptococcus neoformans virulence gene discovery through insertional mutagenesis. Eukaryot. Cell 3:420429.
85. Janbon, G.,, U. Himmelreich,, F. Moyrand,, L. Improvisi, and, F. Dromer. 2001. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neofor-mans capsular polysaccharide. Mol. Microbiol. 42:453467.
86. Kawakami, K.,, M. Tohyama, and, K. Teruya. 1996. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 13:133140.
87. Kidd, S. E.,, F. Hagen,, R. L. Tscharke,, M. Huynh,, K. H. Bartlett,, M. Fyfe,, L. Macdougall,, T. Boekhout,, K. J. Kwon-Chung, and, W. Meyer. 2004. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl. Acad. Sci. USA 101:1725817263.
88. Kingsbury, J. M.,, G. M. Cox, and, J. H. McCusker. 2004. Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37C and for virulence and survival in vivo. Microbiology 150:15471558.
89. Kingsbury, J. M.,, Z. Yang,, T. M. Ganous,, G. M. Cox, and, J. H. McCusker. 2004. A novel chimeric SPE3-LYS9 gene in the human pathogen Cryptococcus neoformans. Eukaryot. Cell 3:752763.
90. Kontoyiannis, D. P.,, W. K. Peitsch, and, B. T. Reddy. 2001. Cryptococcosis in patients with cancer. Clin. Infect. Dis. 32:145150.
91. Kraus, P. R.,, M. J. Boily,, S. S. Giles,, J. E. Stajich,, A. Allen,, G. M. Cox,, F. S. Dietrich,, J. R. Perfect, and, J. Heitman. 2004. Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray. Eukaryot. Cell 3:12491260.
92. Kraus, P. R.,, D. S. Fox,, G. M. Cox, and, J. Heitman. 2003. The Cryptococcus neoformans MAP kinase homolog Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol. Microbiol. 48:13771387.
93. Kwon-Chung, C. J.,, J. C. Edman, and, B. L. Wickes. 1992. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60:602605.
94. Kwon-Chung, K. J. 1975. Filobasidiella the perfect state of Cryptococcus neoformans. Mycologia 67:11971200.
95. Kwon-Chung, K. J., and, J. E. Bennett. 1978. Distribution of “alpha” and “a” mating types of Cryptococcus neoformans among natural and clinical isolates. Am. J. Med. 108:337340.
96. Kwon-Chung, K. J.,, T. Boekhout,, J. W. Fell, and, M. Diaz. 2002. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 51:804806.
97. Kwon-Chung, K. J., and, J. C. Rhodes. 1986. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:218223.
98. Lamb, D. C.,, A. Corran,, B. C. Baldwin,, J. Kwon-Chung, and, S. L. Kelly. 1995. Resistant P45051 A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients. FEBS Lett. 368:326330.
99. Langfelder, K.,, M. Streibel,, B. John,, G. Haase, and, A. Brakhage. 2003. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet. Biol. 38:143158.
100. Lee, H.,, Y. C. Chang, and, K. J. Kwon-Chung. 2005. TUP1 disruption reveals biological differences between MAT a and MAT alpha strains of Cryptococcus neofor-mans. Mol. Microbiol. 55:12221232.
101. Lengeler, K. B.,, G. M. Cox, and, J. Heitman. 2001. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect. Immun 69:115122.
102. Lengeler, K. B.,, P. Wang,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2000. Identification of the MAT a mating-type locus of Cryptococcus neoformans reveals a serotype A MAT a strain thought to have been extinct. Proc. Natl. Acad. Sci. USA 97:1445514460.
103. Levitz, S. M. 1992. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14:S37S42.
104. Levitz, S. M. 1994. Macrophage-Cryptococcus interactions, p. 533543. In B. S. Zwilling and, T. K. Eisenstein (ed.), Macrophage-Pathogen Interactions. Marcel Dekker, Inc., New York, N.Y.
105. Levitz, S. M.,, S. Nong,, M. K. Mansour,, C. Huang, and, C. Specht. 2001. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T-cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 98:1042210427.
106. Litvintseva, A. P.,, R. E. Marra,, K. Nielsen,, J. Heitman,, R. Vilgalys, and, T. G. Mitchell. 2003. Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa. Eukaryot. Cell 2:11621168.
107. Liu, H.,, T. R. Cottrell,, L. M. Pierini,, W. E. Goldman, and, T. L. Doering. 2002. RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics 160:463470.
108. Loftus, B. J.,, E. Fung,, P. Roncaglia,, D. Rowley,, P. Amedeo,, D. Bruno,, J. Vamathevan,, M. Miranda,, I. J. Anderson,, J. A. Fraser,, J. E. Allen,, I. E. Bosdet,, M. R. Brent,, R. Chiu,, T. L. Doering,, M. J. Donlin,, C. A. D’Souza,, D. S. Fox,, V. Grinberg,, J. Fu,, M. Fukushima,, B. J. Haas,, J. C. Huang,, G. Janbon,, S. J. Jones,, H. L. Koo,, M. I. Krzywinski,, J. K. Kwon-Chung,, K. B. Lengeler,, R. Maiti,, M. A. Marra,, R. E. Marra,, C. A. Mathewson,, T. G. Mitchell,, M. Pertea,, F. R. Riggs,, S. L. Salzberg,, J. E. Schein,, A. Shvartsbeyn,, H. Shin,, M. Shumway,, C. A. Specht,, B. B. Suh,, A. Tenney,, T. R. Utterback,, B. L. Wickes,, J. R. Wortman,, N. H. Wye,, J. W. Kronstad,, J. K. Lodge,, J. Heitman,, R. W. Davis,, C. M. Fraser, and, R. W. Hyman. 2005. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307:13211324.
109. Luberto, C.,, D. Taraskiewicz,, B. Martinez-Marino,, B. Bolanos,, P. Chitano,, D. L. Toffaletti,, G. M. Cox,, J. R. Perfect,, Y. A. Hannun,, E. Balish, and, M. Del Poeta. 2003. IPC1 regulates the phagocytosis of Cryptococcus neoformans by macrophages through modulation of the antiphagocytic protein (APP1) phagocytosis and pathogenicity: when host takes control. J. Clin. Investig. 112:10801094.
110. Luberto, C.,, D. L. Toffaletti,, E. A. Wills,, S. C. Tucker,, A. Casadevall,, J. R. Perfect,, Y. A. Hannum, and, M. Del Poeta. 2001. Roles for inositol-phosphorylceramide synthase 1 (IPC1) in pathogenesis of Cryptococcus neoformans. Genes Dev. 15:201212.
111. Mandel, M. A.,, G. G. Grace,, K. I. Osborn,, F. Schafer,, J. W. Murphy,, M. J. Orbach, and, J. N. Galgiani. 2002. The Cryptocococus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice. Infect. Immun. 68:61966201.
112. Marra, R. E.,, J. C. Huang,, E. Fung,, K. Nielsen,, J. Heitman,, R. Vilgalys, and, T. G. Mitchell. 2004. A genetic linkage map of Cryptococcus neoformans variety neoformans serotype D (Filobasidiella neoformans). Genetics 167:619631.
113. Martinez, L. R.,, J. Garcia-Rivera, and, A. Casadevall. 2001. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A strains). J. Clin. Microbiol. 39:33653367.
114. McClelland, E. E.,, F. R. Adler,, D. L. Granger and, W. K. Potts. 2004. Major histocompatibility complex controls the trajectory but not host-specific adaptation during virulence evolution of the pathogenic fungus Cryptococcus neoformans. Proc. R. Soc. Lond. Ser. B. 271:15571564.
115. McDade, H. C., and, G. M. Cox. 2002. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39:151154.
116. McNeill, J. I., and, V. L. Kan. 1995. Decline in the incidence of cryptococcosis among HIV-related patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 206:207208.
117. Meyer, W.,, A. Castaneda,, S. Jackson,, M. Huynh, and, E. Castaneda. 2003. Molecular typing of Ibero American Cryptococcus neoformans isolates. Emerg. Infect. Dis. 9:189195.
118. Mirza, S.,, M. Phelan,, D. Rimland,, E. Graviss,, R. Hamill,, M. E. Brandt,, T. Gardner,, M. Sattah,, G. Ponce de Leon, and, H. R. A. Baughman. 2002. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin. Infect. Dis. 36:789794.
119. Missall, T. A.,, J. K. Lodge, and, J. E. McEwen. 2004. Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts. Eukaryot. Cell 3:835846.
120. Missall, T. A.,, J. M. Moran,, J. A. Corbett, and, J. K. Lodge. 2005. Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1. Eukaryot. Cell 4:202208.
121. Missall, T. A.,, M. E. Pusateri, and, J. K. Lodge. 2004. Thiol peroxidase is critical for virulence and resistance to nitric oxide and peroxide in the fungal pathogen, Cryptococcus neoformans. Mol. Microbiol. 51:14471448.
122. Monari, C.,, F. Bistoni,, A. Casadevall,, E. Pericolini,, D. Pietrella,, T. R. Kozel, and, A. Vecchiarelli. 2005. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J. Infect. Dis. 191:127137.
123. Monari, C.,, E. Pericolini,, G. Bistoni,, E. Cenci,, F. Bistoni, and, A. Vecchiarelli. 2005. Influence of indinavir on virulence and growth of Cryptococcus neoformans. J. Infect. Dis. 191:307311.
124. Mondon, P.,, R. Petter,, G. Amalfitano,, R. Luzzati,, E. Concia,, I. Polacheck, and, K. J. Kwon-Chung. 1999. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob. Agents Che-mother. 43:18561861.
125. Moyrand, F., and, G. Janbon. 2004. UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37°C and for capsule biosynthesis. Eukaryot. Cell 3:16011608.
126. Moyrand, F.,, B. Klaproth,, U. Himmelreich,, F. Dromer, and, G. Janbon. 2002. Isolation and characterization of capsule structure mutant strains of Cryptococcus neofor-mans. Mol. Microbiol. 45:837849.
127. Mukherjee, J.,, M. D. Sharff, and, A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:45344541.
128. Murphy, J. W. 1992. Cryptococcal immunity and immunostimulation. Adv. Exp. Med. Biol. 319:225230.
129. Mylonakis, E.,, F. M. Ausubel,, J. R. Perfect,, J. Heitman, and, S. B. Calderwood. 2002. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. USA 99:1567515680.
130. Mylonakis, E.,, A. Idnurm,, R. Moreno,, J. El Khoury,, J. B. Rottman,, F. M. Ausubel,, J. Heitman, and, S. B. Calderwood. 2004. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol. Microbiol. 54:407419.
131. Narasipura, S. D.,, J. G. Ault,, M. J. Behr,, V. Chaturvedi, and, S. Chaturvedi. 2003. Characterization of Cu, Zn superoxide dismutase (SOD1) gene knock-out mutant of Cryptococcus neoformans var. gattii: role in biology and virulence. Mol. Microbiol. 47:16811694.
132. Nelson, R. T.,, J. Hua,, B. Pryor, and, J. K. Lodge. 2001. Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Genetics 157:935947.
133. Nielsen, K.,, G. M. Cox,, P. Wang,, D. L. Toffaletti,, J. R. Perfect, and, J. Heitman. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect. Immun. 71:48314841.
134. Noverr, M. C.,, G. M. Cox,, J. R. Perfect, and, G. B. Huffnagle. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:15381547.
135. Noverr, M. C.,, P. R. Williamson,, R. S. Fajardo, and, G. B. Huffnagle. 2004. CNLAC1 is required for extra-pulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 72:16931699.
136. O’Brien, C. R.,, M. B. Krockenberger,, D. I. Wigney,, P. Martin, and, R. Malik. 2004. Retrospective study of feline and canine cryptococcosis in Australia from 1981 to 2001: 195 cases. Med. Mycol. 42:449460.
137. Odom, A.,, S. Muir,, E. Lim,, D. L. Toffaletti,, J. R. Perfect, and, J. Heitman. 1997. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16:25762589.
138. Olszewski, M. A.,, M. C. Noverr,, G. H. Chen,, G. B. Toews,, G. M. Cox,, J. R. Perfect, and, G. B. Huffnagle. 2004. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am. J. Pathol. 164:17611771.
139. Ory, J. J.,, C. L. Griffith, and, T. L. Doering. 2004. An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast 21:919926.
140. Pappas, P. G.,, B. Bustamante,, E. Ticona,, R. J. Hamill,, P. C. Johnson,, A. Reboli,, J. Aberg,, R. Hasbun, and, H. H. Hsu. 2004. Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J. Infect. Dis. 189:21852191.
141. Pascon, R. C.,, T. M. Ganous,, J. M. Kingsbury,, G. M. Cox, and, J. H. McCusker. 2004. Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. Microbiology 150:30133023.
142. Perfect, J. R. 2005. Cryptococcus neoformans : a sugar-coated killer with designer genes. FEMs Immunol. Med. Microbiol. 45:395404.
143. Perfect, J. R., and, A. Casadevall. 2002. Cryptococcosis. Infect. Dis. Clin. North Am. 16:837874.
144. Perfect, J. R.,, N. Ketabchi,, G. M. Cox,, C. I. Ingram, and, C. Beiser. 1993. Karyotyping of Cryptococcus neofor-mans as an epidemiological tool. J. Clin. Microbiol. 31:33053309.
145. Perfect, J. R.,, D. L. Toffaletti, and, T. H. Rude. 1993. The gene encoding for phosphoaminoimidazole carboxylase is essential for growth of Cryptococcus neofor-mans in cerebrospinal fluid. Infect. Immun. 61:44464451.
146. Perfect, J. R. 2003. Genetic requirements for virulence in Cryptococcus neoformans. Mycota 12:89112.
147. Pietrella, D.,, B. Fries,, P. Cupo,, F. Bistoni,, A. Casadevall, and, A. Vecchiarelli. 2003. A phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Microbiology 5:513522.
148. Posteraro, B.,, M. Sanguinetti,, D. Sanglard,, M. La Sorda,, S. Boccia,, L. Romano,, G. Morace, and, G. Fadda. 2003. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol. Microbiol. 47:357371.
149. Pukkila-Worley, R.,, Q. D. Gerrald,, P. R. Kraus,, M. J. Boily,, M. J. Davis,, S. S. Giles,, G. M. Cox,, J. Heitman, and, J. A. Alspaugh. 2005. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot. Cell 4:190201.
150. Rhodes, J. C.,, L. S. Wicker, and, W. J. Urba. 1980. Genetic control of susceptibility to Cryptococcus neofor-mans in mice. Infect. Immun. 29:494499.
151. Rivera, J.,, M. Feldmesser,, M. Cammer, and, A. Casadevall. 1998. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun. 66:50275030.
152. Rodero, L.,, E. Mellado,, A. C. Rodriguez,, A. Salve,, L. Guelfand,, P. Cahn,, M. Cuenca-Estrella,, G. Davel, and, J. L. Rodriguez-Tudela. 2003. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob. Agents Chemother. 47:36533656.
153. Rosas, A. L.,, J. D. Nosanchuk, and, M. Feldmesser. 2000. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect. Immun. 68:28452853.
154. Rude, T. H.,, D. L. Toffaletti,, G. M. Cox, and, J. R. Perfect. 2002. Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans. Infect. Immun. 70:56845694.
155. Salas, S. D.,, J. E. Bennett,, K. J. Kwon-Chung,, J. R. Perfect, and, P. R. Williamson. 1996. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neofor-mans. J. Exp. Med. 184:377386.
156. Santangelo, R.,, H. Zoellner,, T. Sorrell,, C. Wilson,, C. Donald,, J. Djordjevic,, Y. Shounan, and, L. Wright. 2004. Role of extracellular phospholipases and mononu-clear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun. 72:22292239.
157. Schiappa, D.,, A. Gueylkian,, J. A. Alspaugh,, J. R. Perfect, and, P. R. Williamson. 2002. Myelotropism and auxotrophy of a pigmented Cryptococcus neoformans. Med. Mycol. 40:16.
158. Schimpff, S. C., and, J. E. Bennett. 1975. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J. Allergy Clin. Immunol. 55:430441.
159. Shelburne, S. A., III, and, R. J. Hamill. 2003. The immune reconstitution inflammatory syndrome. AIDS Rev. 5:6779.
160. Shen, W. C.,, R. C. Davidson,, G. M. Cox, and, J. Heitman. 2002. Pheromones stimulate mating and differentiation via paracrine and autocrine signaling in Cryptococcus neoformans. Eukaryot. Cell 1:366377.
161. Speed, B., and, D. Dunt. 1995. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21:2834.
162. Spitzer, E. D.,, S. G. Spitzer,, L. F. Freundlich, and, A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595596.
163. Steen, B. R.,, T. Lian,, S. Zuyderduyn,, W. K. MacDonald,, M. Marra,, S. J. M. Jones, and, J. W. Kronstad. 2002. Temperature-related transcription in the pathogenic fungus Cryptococcus neoformans. Genome Res. 12:13861400.
164. Steen, B. R.,, S. Zuyderduyn,, D. L. Toffaletti,, M. Marra,, S. J. Jones,, J. R. Perfect, and, J. Kronstad. 2003. Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryot. Cell 2:13361349.
165. Steenbergen, J. N.,, H. A. Shuman, and, A. Casadevall. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. USA 98:1524515250.
166. Steenbergen, J. N.,, H. A. Shuman, and, A. Casadevall. 2003. Cryptococcus neoformans is enhanced after growth in the genetically malleable host, Dictyostelium discoideum. Infect. Immun. 71:48624872.
167. Sukroongreung, S.,, K. Kitiniyom,, C. Nilakul, and, S. Tantimavanich. 1998. Pathogenicity of basidiospores of Filobasidiella neoformans var. neoformans. Med. Mycol. 36:419424.
168. Sullivan, D.,, K. Haynes,, G. Moran,, D. Shanley, and, D. Coleman. 1996. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J. Clin. Microbiol. 34:17391744.
169. Thompson, J. R.,, C. M. Douglas,, N. Li,, K. J. Chang,, B. Pramanik,, X. Yuan,, T. H. Rude,, D. L. Toffaletti,, J. R. Perfect, and, M. Kurtz. 1999. A glucan synthase FKS1 homolog in Cryptococcus is a single copy and encodes an essential function. J. Bacteriol. 181:444453.
170. Toffaletti, D. L.,, M. Del Poeta,, T. H. Rude,, F. S. Dietrich, and, J. R. Perfect. 2003. Regulation of cytochrome C oxidase subunit 1 (COX1) expression in Cryptococcus neoformans by temperature and host environment. Microbiology 149:10411049.
171. Toffaletti, D. L.,, K. Nielsen,, F. Dietrich,, J. Heitman, and, J. R. Perfect. 2004. Cryptococcus neoformans mitochondrial genomes from serotype A and D strains do not influence virulence. Curr. Genet. 46:193204.
172. Toffaletti, D. L., and, J. R. Perfect. 1997. Study of Cryptococcus neoformans actin gene regulation with a beta-galactosidase-actin fusion. J. Med. Vet. Mycol. 35:313320.
173. Toffaletti, D. L.,, T. H. Rude,, S. A. Johnston,, D. T. Durack, and, J. R. Perfect. 1993. Gene transfer in Cryptococcus neoformans using biolistic delivery of DNA. J. Bacteriol. 175:14051411.
174. Torres, H. A.,, V. G. Prieto,, I. I. Raad, and, D. P. Kontoyiannis. 2005. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cryptococcus neoformans. Mycoses 48:2124.
175. Vallim, M. A.,, L. Fernandes, and, J. A. Alspaugh. 2004. The RAM1 gene encoding a protein-farnesyltransferase beta-subunit homologue is essential in Cryptococcus neoformans. Microbiology 150:19251935.
176. Van de Perre, P.,, P. Lepage, and, P. Kestelyn. 1984. Acquired immunodeficiency syndrome in Rwanda. Lancet ii:6265.
177. van der Horst, C. M.,, M. S. Saag,, G. A. Cloud, and National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. 1997. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 337:1521.
178. van Duin, D.,, A. Casadevall, and, J. D. Nosanchuk. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46:33943400.
179. van Elden, L. J.,, A. M. Walenkamp, and, M. M. Lipovsky. 2000. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 14:27872788.
180. Vartivarian, S. E.,, E. J. Anaissie,, R. E. Cowart,, H. A. Sprigg,, M. J. Tingler, and, E. J. Jacobson. 1993. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167:186190.
181. Velegraki, A.,, V. G. Klosses,, A. Kansovzidov,, S. Smilakov,, A. Mitroussia-Ziouua, and, N. J. Legakis. 2004. Prospective use of RFLP analysis on amplified Cryptococcus neoformans URA5 gene sequences for rapid identification of varieties and serotypes in clinical samples. Med. Mycol. 39:409417.
182. Wang, P.,, M. E. Cardenas,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2001. Two cyclophilin A homologs with shared and distinct functions are expressed in Cryptococcus neoformans. EMBO Rep. 21:511518.
183. Wang, P.,, G. M. Cox, and, J. Heitman. 2004. A Sch9 protein kinase homologue controlling virulence independently of the cAMP pathway in Cryptococcus neoformans. Curr. Genet. 46:247255.
184. Wang, P.,, J. Cutler,, J. King, and, D. Palmer. 2004. Mutation of the regulator of G protein signaling Crg1 increases virulence in Cryptococcus neoformans. Eukaryot. Cell 3:10281035.
185. Wang, P.,, C. S. Nichols,, K. B. Lengeler,, M. E. Cardenas,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 2002. Mating type specific and nonspecific PAK kinases play shared and divergent role in cytokinesis, differentiation and virulence of Cryptococcus neoformans. Eukaryot. Cell 1:257272.
186. Wang, P.,, J. R. Perfect, and, J. Heitman. 2000. The G-protein beta subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans. Mol. Cell. Biol. 20:352362.
187. Wickes, B. L.,, M. E. Mayorga,, U. Edman, and, J. C. Edman. 1996. Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc. Natl. Acad. Sci. USA 93:73277331.
188. Wickes, B., and, J. Edman. 1995. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol. Microbiol. 16:10991109.
189. Wills, E. A.,, I. S. Roberts,, M. Del Poeta,, J. Rivera,, A. Casadevall,, G. M. Cox, and, J. R. Perfect. 2001. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol. Microbiol. 40:610620.
190. Wormley, F. L.,, G. M. Cox, and, J. R. Perfect. 2005. Evaluation of host immune responses to pulmonary cryptococcosis using calcineurin mutant strain. Microb. Pathog. 38:113123.
191. Xu, J. 2004. Genotype-environment interactions of spontaneous mutations for vegetative fitness in the human pathogenic fungus Cryptococcus neoformans. Genetics 168:11771188.
192. Xu, J.,, R. Vilgalys, and, T. G. Mitchell. 2002. Multiple gene genealogies reveal recent dispersion and hybridization in the human fungus, Cryptococcus neoformans. Mol. Ecol. 9:14711481.
193. Yang, Z.,, R. C. Pascon,, J. A. Alspaugh,, G. M. Cox, and, J. H. McCusker. 2002. Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148:26172625.
194. Yauch, L. E.,, M. K. Mansour,, S. Shoham,, J. B. Rottman, and, S. M. Levitz. 2004. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72:53735382.
195. Yue, C.,, L. Cavallo,, J. A. Alspaugh,, G. M. Cox,, J. R. Perfect, and, J. Heitman. 1999. The STE12 homolog is required for haploid filamentation but dispensable for mating and virulence in Cryptococcus neoformans. Genetics 153:16011615.
196. Zaragoza, O., and, A. Casadevall. 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proc. Online 6:1015.
197. Zhu, X., and, P. R. Williamson. 2003. A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans. Mol. Microbiol. 50:12711281.
198. Zhu, X., and, P. R. Williamson. 2004. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res. 5:110.

Tables

Generic image for table
Table 1.

Site-specific gene disruptants in and their impact on virulence in animal models

Citation: Perfect J. 2006. : a Sugar-Coated Killer, p 281-303. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch21
Generic image for table
Table 2.

Genes linked to the major virulence phenotypes of

Citation: Perfect J. 2006. : a Sugar-Coated Killer, p 281-303. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch21
Generic image for table
Table 3.

Examples of the relative impact of gene disruptants on virulence in mice

Citation: Perfect J. 2006. : a Sugar-Coated Killer, p 281-303. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch21

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error